Abstract
Understanding the stability of the shrimp allergen tropomyosin (TM) in shrimp powder at different temperatures is necessary to develop shrimp oral immunotherapy (SOIT). We evaluated the shrimp TM stability for different storage times for utilization in a SOIT clinical trial and determined the specific IgE (sIgE) binding capacity of raw and cooked shrimp allergen extracts.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
